SCHEMBL6460314

SCHEMBL6460314

CN1CCCCN1c1ccc(NC(=O)C2(NC(=O)c3ccc(Cl)s3)CCOC2)cc1C(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
F10 P00742 13/20 0.45
CYP2C9 P11712 1/20 0.37
MAPT P10636 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
TP53 P04637 1/20 0.36
THRB P10828 1/20 0.36
MEN1 O00255 2/20 0.35
ALDH1A1 P00352 2/20 0.35
KMT2A Q03164 2/20 0.35
HTT P42858 1/20 0.35
NPC1 O15118 1/20 0.35
HPGD P15428 1/20 0.35
NFKB1 P19838 1/20 0.35
RAB9A P51151 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
BRAF P15056 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6454195 0.91 F10 (0.43) F10MAPTMEN1ALDH1A1KMT2A
SCHEMBL6459619 0.90 F10 (0.42) F10MAPTSMN1; SMN2MEN1ALDH1A1
SCHEMBL6454183 0.90 F10 (0.45) F10MAPTSMN1; SMN2MEN1ALDH1A1
SCHEMBL6455256 0.89 F10 (0.38) F10MAPTSMN1; SMN2MEN1ALDH1A1
SCHEMBL6461396 0.85 F10 (0.42) F10MAPTSMN1; SMN2MEN1ALDH1A1
SCHEMBL6454187 0.83 F10 (0.47) F10MAPTMEN1ALDH1A1KMT2A
SCHEMBL6454489 0.80 CTSL (0.39) F10MAPTSMN1; SMN2TP53MEN1
SCHEMBL3766845 0.78 KMT2A (0.42) F10MAPTSMN1; SMN2MEN1ALDH1A1
SCHEMBL3781597 0.78 KMT2A (0.42) F10MAPTSMN1; SMN2MEN1ALDH1A1
SCHEMBL2573467 0.78 KMT2A (0.42) F10MAPTSMN1; SMN2MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050256107-A1 New substituted thiophene carboxamides, process for their preparation and their use as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256107-A1 New substituted thiophene carboxamides, process for their preparation and their use as medicaments OTC, TPMT, ABCG2 F10 1901/4885CYP2C9 103/4885MAPT 1066/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.